BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Doyen J, Falk AT, Floquet V, Hérault J, Hannoun-Lévi JM. Proton beams in cancer treatments: Clinical outcomes and dosimetric comparisons with photon therapy. Cancer Treat Rev 2016;43:104-12. [PMID: 26827698 DOI: 10.1016/j.ctrv.2015.12.007] [Cited by in Crossref: 40] [Cited by in F6Publishing: 36] [Article Influence: 8.0] [Reference Citation Analysis]
Number Citing Articles
1 Stützer K, Lin A, Kirk M, Lin L. Superiority in Robustness of Multifield Optimization Over Single-Field Optimization for Pencil-Beam Proton Therapy for Oropharynx Carcinoma: An Enhanced Robustness Analysis. Int J Radiat Oncol Biol Phys 2017;99:738-49. [PMID: 29280468 DOI: 10.1016/j.ijrobp.2017.06.017] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
2 Ohlsson-Nevo E, Furberg M, Giørtz M, Johansson B, Kristensen I, Kunni K, Langegård U, Lysemose Poulsen R, Striem J, Tømmerås V, Wilhøft Kristensen A, Winther D, Sjövall K. Patients' perspective in the context of proton beam therapy: summary of a Nordic workshop. Acta Oncol 2020;59:1139-44. [PMID: 32536238 DOI: 10.1080/0284186X.2020.1762927] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Gordon K, Gulidov I, Semenov A, Golovanova O, Koryakin S, Makeenkova T, Ivanov S, Kaprin A. Proton re-irradiation of unresectable recurrent head and neck cancers. Rep Pract Oncol Radiother 2021;26:203-10. [PMID: 34211770 DOI: 10.5603/RPOR.a2021.0029] [Reference Citation Analysis]
4 Teoh S, Fiorini F, George B, Vallis KA, Van den Heuvel F. Is an analytical dose engine sufficient for intensity modulated proton therapy in lung cancer? Br J Radiol 2020;93:20190583. [PMID: 31696729 DOI: 10.1259/bjr.20190583] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
5 Tommasino F, Widesott L, Fracchiolla F, Lorentini S, Righetto R, Algranati C, Scifoni E, Dionisi F, Scartoni D, Amelio D, Cianchetti M, Schwarz M, Amichetti M, Farace P. Clinical implementation in proton therapy of multi-field optimization by a hybrid method combining conventional PTV with robust optimization. Phys Med Biol 2020;65:045002. [PMID: 31851957 DOI: 10.1088/1361-6560/ab63b9] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 7.0] [Reference Citation Analysis]
6 Marvaso G, Vischioni B, Jereczek-Fossa BA, Ciardo D, Fossati P, Giandini T, Morlino S, Carrara M, Romanelli P, Russi E, Valvo F, Valdagni R, Orecchia R. Hadrontherapy from the Italian Radiation Oncologist point of view: face the reality. The Italian Society of Oncological Radiotherapy (AIRO) survey. Radiol Med 2017;122:140-5. [PMID: 27770265 DOI: 10.1007/s11547-016-0699-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
7 Cirrone GAP, Manti L, Margarone D, Petringa G, Giuffrida L, Minopoli A, Picciotto A, Russo G, Cammarata F, Pisciotta P, Perozziello FM, Romano F, Marchese V, Milluzzo G, Scuderi V, Cuttone G, Korn G. First experimental proof of Proton Boron Capture Therapy (PBCT) to enhance protontherapy effectiveness. Sci Rep 2018;8:1141. [PMID: 29348437 DOI: 10.1038/s41598-018-19258-5] [Cited by in Crossref: 28] [Cited by in F6Publishing: 16] [Article Influence: 9.3] [Reference Citation Analysis]
8 Souici M, Khalil TT, Muller D, Raffy Q, Barillon R, Belafrites A, Champion C, Fromm M. Single- and Double-Strand Breaks of Dry DNA Exposed to Protons at Bragg-Peak Energies. J Phys Chem B 2017;121:497-507. [DOI: 10.1021/acs.jpcb.6b11060] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 3.3] [Reference Citation Analysis]
9 Shang H, Pu Y, Chen Z, Wang X, Yuan C, Jin X, Liu C. Impact of Multiple Beams on Plan Quality, Linear Energy Transfer Distribution, and Plan Robustness of Intensity Modulated Proton Therapy for Lung Cancer. ACS Sens 2021;6:408-17. [PMID: 33125211 DOI: 10.1021/acssensors.0c01879] [Reference Citation Analysis]
10 Xi M, Lin SH. Recent advances in intensity modulated radiotherapy and proton therapy for esophageal cancer. Expert Rev Anticancer Ther 2017;17:635-46. [PMID: 28503964 DOI: 10.1080/14737140.2017.1331130] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 3.8] [Reference Citation Analysis]
11 Ahn SH, Lee N, Choi C, Shin SW, Han Y, Park HC. Feasibility study of Fe 3 O 4 /TaO x nanoparticles as a radiosensitizer for proton therapy. Phys Med Biol 2018;63:114001. [DOI: 10.1088/1361-6560/aac27b] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
12 Hwang EJ, Gorayski P, Le H, Hanna GG, Kenny L, Penniment M, Buck J, Thwaites D, Ahern V. Particle therapy toxicity outcomes: A systematic review. J Med Imaging Radiat Oncol 2020;64:725-37. [PMID: 32421259 DOI: 10.1111/1754-9485.13036] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
13 Whittle SB, Smith V, Doherty E, Zhao S, McCarty S, Zage PE. Overview and recent advances in the treatment of neuroblastoma. Expert Rev Anticancer Ther. 2017;17:369-386. [PMID: 28142287 DOI: 10.1080/14737140.2017.1285230] [Cited by in Crossref: 115] [Cited by in F6Publishing: 110] [Article Influence: 28.8] [Reference Citation Analysis]
14 Ning MS, Palmer MB, Shah AK, Chambers LC, Garlock LB, Melson BB, Frank SJ. Three-Year Results of a Prospective Statewide Insurance Coverage Pilot for Proton Therapy: Stakeholder Collaboration Improves Patient Access to Care. JCO Oncol Pract 2020;16:e966-76. [PMID: 32302271 DOI: 10.1200/JOP.19.00437] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
15 Elder BD, Ishida W, Goodwin CR, Bydon A, Gokaslan ZL, Sciubba DM, Wolinsky JP, Witham TF. Bone graft options for spinal fusion following resection of spinal column tumors: systematic review and meta-analysis. Neurosurg Focus 2017;42:E16. [PMID: 28041327 DOI: 10.3171/2016.8.FOCUS16112] [Cited by in Crossref: 13] [Cited by in F6Publishing: 3] [Article Influence: 3.3] [Reference Citation Analysis]
16 Jones DA, Smith J, Mei XW, Hawkins MA, Maughan T, van den Heuvel F, Mee T, Kirkby K, Kirkby N, Gray A. A systematic review of health economic evaluations of proton beam therapy for adult cancer: Appraising methodology and quality. Clin Transl Radiat Oncol 2020;20:19-26. [PMID: 31754652 DOI: 10.1016/j.ctro.2019.10.007] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
17 Mee T, Kirkby NF, Kirkby KJ. Mathematical Modelling for Patient Selection in Proton Therapy. Clin Oncol (R Coll Radiol) 2018;30:299-306. [PMID: 29452724 DOI: 10.1016/j.clon.2018.01.007] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.7] [Reference Citation Analysis]
18 De Marzi L, Patriarca A, Nauraye C, Hierso E, Dendale R, Guardiola C, Prezado Y. Implementation of planar proton minibeam radiation therapy using a pencil beam scanning system: A proof of concept study. Med Phys 2018;45:5305-16. [PMID: 30311639 DOI: 10.1002/mp.13209] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
19 Doyen J, Aloi D, Groulier A, Vidal M, Lesueur P, Calugaru V, Bondiau PY. Role of proton therapy in reirradiation and in the treatment of sarcomas. Cancer Radiother 2021:S1278-3218(21)00123-2. [PMID: 34284969 DOI: 10.1016/j.canrad.2021.06.024] [Reference Citation Analysis]
20 Gjyshi O, Liao Z. Proton therapy for locally advanced non-small cell lung cancer. Br J Radiol 2020;93:20190378. [PMID: 31430188 DOI: 10.1259/bjr.20190378] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
21 Doyen J, Sunyach MP, Almairac F, Bourg V, Naghavi AO, Duhil de Bénazé G, Claren A, Padovani L, Benezery K, Noël G, Hannoun-Lévi JM, Guedea F, Giralt J, Vidal M, Baudin G, Opitz L, Claude L, Bondiau PY. Early Toxicities After High Dose Rate Proton Therapy in Cancer Treatments. Front Oncol 2020;10:613089. [PMID: 33520724 DOI: 10.3389/fonc.2020.613089] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
22 Spiotto MT, McGovern SL, Gunn GB, Grosshans D, McAleer MF, Frank SJ, Paulino AC. Proton Radiotherapy to Reduce Late Complications in Childhood Head and Neck Cancers. Int J Part Ther 2021;8:155-67. [PMID: 34285943 DOI: 10.14338/IJPT-20-00069.1] [Reference Citation Analysis]
23 Meerz A, Deville SS, Müller J, Cordes N. Comparative Therapeutic Exploitability of Acute Adaptation Mechanisms to Photon and Proton Irradiation in 3D Head and Neck Squamous Cell Carcinoma Cell Cultures. Cancers (Basel) 2021;13:1190. [PMID: 33801853 DOI: 10.3390/cancers13061190] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
24 Smith WL, Smith CD, Patel S, Eisenstat DD, Quirk S, Mackenzie M, Olivotto IA. What Conditions Make Proton Beam Therapy Financially Viable in Western Canada? Cureus 2018;10:e3644. [PMID: 30723643 DOI: 10.7759/cureus.3644] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
25 Stokkevåg CH, Schneider U, Muren LP, Newhauser W. Radiation-induced cancer risk predictions in proton and heavy ion radiotherapy. Physica Medica 2017;42:259-62. [DOI: 10.1016/j.ejmp.2017.04.022] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 3.8] [Reference Citation Analysis]
26 Doyen J, Bondiau PY, Benezery K, Thariat J, Vidal M, Gérard A, Hérault J, Carrie C, Hannoun-Lévi JM. [Indications and results for protontherapy in cancer treatments]. Cancer Radiother 2016;20:513-8. [PMID: 27614508 DOI: 10.1016/j.canrad.2016.06.005] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.2] [Reference Citation Analysis]
27 Frisch S, Timmermann B. The Evolving Role of Proton Beam Therapy for Sarcomas. Clinical Oncology 2017;29:500-6. [DOI: 10.1016/j.clon.2017.04.034] [Cited by in Crossref: 33] [Cited by in F6Publishing: 24] [Article Influence: 8.3] [Reference Citation Analysis]
28 Vaios EJ, Wo JY. Proton beam radiotherapy for anal and rectal cancers. J Gastrointest Oncol 2020;11:176-86. [PMID: 32175121 DOI: 10.21037/jgo.2019.04.03] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
29 Sylvester CB, Abe JI, Patel ZS, Grande-Allen KJ. Radiation-Induced Cardiovascular Disease: Mechanisms and Importance of Linear Energy Transfer. Front Cardiovasc Med 2018;5:5. [PMID: 29445728 DOI: 10.3389/fcvm.2018.00005] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 7.7] [Reference Citation Analysis]
30 Bayart E, Flacco A, Delmas O, Pommarel L, Levy D, Cavallone M, Megnin-Chanet F, Deutsch E, Malka V. Fast dose fractionation using ultra-short laser accelerated proton pulses can increase cancer cell mortality, which relies on functional PARP1 protein. Sci Rep 2019;9:10132. [PMID: 31300704 DOI: 10.1038/s41598-019-46512-1] [Cited by in Crossref: 24] [Cited by in F6Publishing: 16] [Article Influence: 12.0] [Reference Citation Analysis]
31 Hohmann S, Deisher AJ, Suzuki A, Konishi H, Rettmann ME, Merrell KW, Kruse JJ, Newman LK, Parker KD, Monahan KH, Foote RL, Herman MG, Packer DL. Left ventricular function after noninvasive cardiac ablation using proton beam therapy in a porcine model. Heart Rhythm 2019;16:1710-9. [DOI: 10.1016/j.hrthm.2019.04.030] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 7.5] [Reference Citation Analysis]
32 Musielak M, Suchorska WM, Fundowicz M, Milecki P, Malicki J. Future Perspectives of Proton Therapy in Minimizing the Toxicity of Breast Cancer Radiotherapy. J Pers Med 2021;11:410. [PMID: 34068305 DOI: 10.3390/jpm11050410] [Reference Citation Analysis]
33 Lupu-Plesu M, Claren A, Martial S, N'Diaye PD, Lebrigand K, Pons N, Ambrosetti D, Peyrottes I, Feuillade J, Hérault J, Dufies M, Doyen J, Pagès G. Effects of proton versus photon irradiation on (lymph)angiogenic, inflammatory, proliferative and anti-tumor immune responses in head and neck squamous cell carcinoma. Oncogenesis 2017;6:e354. [PMID: 28671677 DOI: 10.1038/oncsis.2017.56] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 5.8] [Reference Citation Analysis]
34 Ning MS, Gomez DR, Shah AK, Kim CR, Palmer MB, Thaker NG, Grosshans DR, Liao Z, Chapman BV, Brooks ED, Tang C, Rosenthal DI, Garden AS, Frank SJ, Gunn GB. The Insurance Approval Process for Proton Radiation Therapy: A Significant Barrier to Patient Care. International Journal of Radiation Oncology*Biology*Physics 2019;104:724-33. [DOI: 10.1016/j.ijrobp.2018.12.019] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 10.0] [Reference Citation Analysis]
35 Bishop AJ, Livingston JA, Ning MS, Valdez ID, Wages CA, McAleer MF, Paulino AC, Grosshans DR, Woodhouse KD, Tao R, Roth ME, Gunn GB, McGovern SL. Young Adult Populations Face Yet Another Barrier to Care With Insurers: Limited Access to Proton Therapy. Int J Radiat Oncol Biol Phys 2021;110:1496-504. [PMID: 33677051 DOI: 10.1016/j.ijrobp.2021.02.049] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
36 Hohmann S, Deisher AJ, Konishi H, Rettmann ME, Suzuki A, Merrell KW, Kruse JJ, Fitzgerald ST, Newman LK, Parker KD, Monahan KH, Foote RL, Herman MG, Packer DL. Catheter-free ablation of infarct scar through proton beam therapy: Tissue effects in a porcine model. Heart Rhythm 2020;17:2190-9. [DOI: 10.1016/j.hrthm.2020.07.011] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]